A. Salerno

Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One

A. Milelli, M. Bolognesi, Francesca Seghetti, 2022, Journal of medicinal chemistry.

CSF of SARS-CoV-2 patients with neurological syndromes reveals hints to understand pathophysiology

G. Pantaleo, R. D. Du Pasquier, Gilbert GREUB, 2020, medRxiv.

Innovative Approach for a Classic Target: Fragment Screening on Trypanothione Reductase Reveals New Opportunities for Drug Design

A. Ilari, A. Fiorillo, Francesca Seghetti, 2022, Frontiers in Molecular Biosciences.

Lamin B autoantibodies in sera of certain patients with systemic lupus erythematosus

G. Blobel, W. Reeves, N. Chaudhary, 1987, The Journal of experimental medicine.

Riluzole–Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis

Maicol Bissaro, S. Moro, M. Bolognesi, 2022, ACS chemical neuroscience.

Targeted Protein Degradation for Infectious Diseases: from Basic Biology to Drug Discovery

A. Milelli, M. Bolognesi, A. Ilari, 2022, ACS bio & med chem Au.

From combinations to multitarget‐directed ligands: A continuum in Alzheimer's disease polypharmacology

Claudia Albertini, Alessandra Salerno, Pedro de Sena Murteira Pinheiro, 2020, Medicinal research reviews.

Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer’s Disease

M. Bartolini, M. Bolognesi, O. Soukup, 2021, Journal of medicinal chemistry.